Siolta Therapeutics Alternatives & Competitors

12 companies similar to Siolta Therapeutics

Scioto Biosciences, Inc

7 Series B $30.96M

Indianapolis, United Stat...

Biotechnology Health Care +2

Prometheus Biosciences, Inc.

Revolutionizing medicine with precision.

31 Post-IPO Equity $951.84M

San Diego, United States

Biotechnology Health Care +2

Allakos Inc

Antibody-based therapeutics to treat various allergies and diseases

24 Acquired $388.00M

Redwood City, United Stat...

Biopharma Biotechnology +2

Q32 Bio Inc.

Revolutionizing the future of targeted immune therapeutics

28 $255.50M

Waltham, United States

Biotechnology Health Care +1

Track all Siolta Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Oxford BioTherapeutics

Redefining the cancer-immune synapse for novel immune checkpoint mechanisms

66 $28.09M

Oxford, United Kingdom

Biotechnology Health Care +1

Therini Bio, Inc.

A new approach to block vascular-mediated inflammation

15 Series A $65.35M

Sacramento, United States

Biotechnology Health Care +1

Upstream Bio

Developing treatments for inflammatory diseases

78 IPO $693.00M

Waltham, United States

Biotechnology Health Care +2

Serpin Pharma

Enhancing cell resilience: A revolutionary approach for inflammatory diseases

8 Grant $400.00K

Manassas, United States

Biotechnology Health Care +1

Nuvig Therapeutics Inc.

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

24 Series A $47.00M

Menlo Park, United States

Biotechnology Health Care +1

Applied Molecular Transport

We are committed to developing transformational biologic medicines to serve patients with...

17 Post-IPO Equity $193.70M

South San Francisco, Unit...

Biotechnology Health and Wellness

Enlivex Therapeutics (Nasdaq: ENLV)

Immune rebalancing

41 Post-IPO Equity

Israel

Biotechnology Health Care +1

Delinia

Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus o...

3 Acquired $335.00M

San Francisco, United Sta...

Biotechnology Health and Wellness

About Siolta Therapeutics

Siolta Therapeutics is a clinical-stage biotech company founded in 2016 with its headquarters in San Carlos, CA. The company focuses on developing live biotherapeutics to address medical needs in various conditions. Recently, on 12 March 2024, Siolta Therapeutics secured a noteworthy $12.00M Series C investment from ke...

Taxonomy

Clinical-stage Biotech, Live Biotherapeutics, Human Microbiome Therapeutics, Inflammatory Diseases, Microbial Therapeutics, Companion Diagnostics, Gut Microbiome, Immune Tolerance, Medical Research, Host-microbe Interactions, Pharmaceutical Development, San Carlos, Microbiome, Biotech, Immune System

Frequently Asked Questions

Companies similar to Siolta Therapeutics include Scioto Biosciences, Inc, Prometheus Biosciences, Inc., Allakos Inc, Q32 Bio Inc., Oxford BioTherapeutics. They work in Biotechnology and Health and Wellness and share Siolta Therapeutics's focus on inflammatory diseases, biotech and companion diagnostics.

Bounce Watch lists 12 companies that share Siolta Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Siolta Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Siolta Therapeutics Profile Scioto Biosciences, Inc Alternatives Prometheus Biosciences, Inc. Alternatives Allakos Inc Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Siolta Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.